What’s New

News Nov 18, 2024
Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial

September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality…

Publication Nov 6, 2024
Efficacy and Safety of Advanced Combination Treatment in Immune-Mediated Inflammatory Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Christopher Ma, Vipul Jairath, Virginia Salitano

Publication Jan 11, 2018
Disease Activity Indices in Coeliac Disease: Systematic Review and Recommendations for Clinical Trials

Brian Feagan, Geert D’Haens, Vipul Jairath

Publication Jan 5, 2018
The Expanding Therapeutic Armamentarium for Inflammatory Bowel Disease: How to Choose the Right Drug[s] for Our Patients?

Brian Feagan, Geert D’Haens, Niels Vande Casteele, Vipul Jairath

Publication Nov 2, 2017
Centrally Determined Standardization of Flow Cytometry Methods Reduces Interlaboratory Variation in a Prospective Multicenter Study

Brian Feagan, Geert D’Haens, Niels Vande Casteele, Vipul Jairath

Publication Oct 17, 2017
Systematic Review: Disease Activity Indices in Eosinophilic Esophagitis

Brian Feagan, Geert D’Haens, Vipul Jairath

Publication Sep 8, 2017
Placebo Response and Remission Rates in Randomised Trials of Induction and Maintenance Therapy for Ulcerative Colitis

Brian Feagan, Geert D’Haens, Guangyong Zou, Vipul Jairath

Publication Aug 26, 2017
Alicaforsen for the Treatment of Inflammatory Bowel Disease

Brian Feagan, Vipul Jairath